This MedLibrary.org supplementary page on Levorphanol is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
|
Levorphanol
|
|
| Systematic (IUPAC) name | |
| 17-methylmorphinan-3-ol | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H23NO |
| Mol. mass | 257.371 g/mol |
| SMILES | & |
| Physical data | |
| Melt. point | 23 °C (73 °F) |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 40% |
| Metabolism | ? |
| Half life | 11-16 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C(US) |
| Legal status | |
| Routes | oral, intravenous, intramuscular, subcutaneous |
Levorphanol (Levo-Dromoran) is an opioid medication used to treat severe pain. It is the laevorotary stereoisomer of the synthetic drug morphinan (Dromoran) and a pure opioid agonist, first described in Germany in 1946 as an orally active morphine-like analgesic. Morphinan is the parent drug and prototype of a large series of opioid and/or NMDA pure or mixed antagonists used in medicine including nalbuphine, butorphanol, dextromethorphan, and others. One morphinan derivative, cyclorphan was found to be highly hallucinogenic and psychotomimetic and have other untoward effects and of course was never marketed as an analgesic.
Levorphanol has the same properties as morphine with respect to the potential for habituation, tolerance, physical dependence and withdrawal syndrome. 30 mg of oral morphine is roughly equianalgesic to 4 mg of oral levorphanol.[1] The laevo isomer is the source of the narcotic properties of the racaemic drug Dromoran, but the dextro isomers are also useful in medicine: in addition to acting on sigma opioid receptors, the O-methyl derivative of its dextrorotary isomer, dextromethorphan, acts as an NMDA receptor antagonist.[2] Oral doses of levorphanol come in 2 mg and 4 mg strengths or subcutaneous injection every 6 to 8 hours.
Levorphanol has affinity to μ, κ, and δ opioid receptors, but lacks complete cross-tolerance with morphine. The duration of action is generally long compared to other comparable analgesics, and varies from 4 hours to as much as 15 hours. For this reason levorphanol is useful in palliation of chronic pain and similar conditions. Levorphanol has an oral to parenteral effectiveness ratio of 2:1, one of the most favourable of the strong narcotics. Its NMDA actions, similar to those of the phenylheptylamine open-chain narcotics such as methadone and ketobemidone, make levorphanol useful for types of pain that other analgesics may not be as effective against.
It is chemically related to dextromethorphan, an antitussive which is not an analgesic. Dextromethorphan is a salt of the methyl ether dextrorotatory isomer of levorphanol.
Notes
- ^ www.globalrph.com/narcoticonv.htm
- ^ Brookoff D. Hospital Practice. 2000;35:45-59.
 |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 11 October 2008, at 03:00.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Levorphanol".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.